title: A new clinical-scale serum-free xeno-free medium efficient in ex vivo amplification of mesenchymal stromal cells does not support mesenchymal stem cells.
abstract: We evaluated a new serum-free, xeno-free medium (Xuri, GE HealthCare) in ex vivo cultures for amplification of mesenchymal stromal cells (MStroC) in comparison with classical culture supplemented with fetal calf serum and basic fibroblast growth factor.
  
  
  
  MStroC and mesenchymal stem cell (MSC) proliferative capacities were studied in bulk cultures and single-cell cultures with assay of secondary replating capacity of individual clones. Flow-cytometric phenotype analysis and proliferative history analysis were also performed.
  
  
  
  In cultures initiated with previously amplified and cryopreserved MStroC from human marrow, Xuri medium enabled a total cell expansion fold comparable to one obtained in control fetal calf serum (FCS)-supplemented culture. However, both the number and the proliferative capacity of colony-forming unit-fibroblast were greatly reduced in Xuri medium cultures. This is even more evident in single-cell cultures, where, in rare positive wells, only several cells were found in Xuri cultures, compared to abundant cell content in FCS and α-minimal essential medium cultures. Replating these single-cell clones in secondary cultures (FCS in both cases) revealed a total exhaustion of MSC proliferative capacity after Xuri primary culture.
  
  
  
  Since in both conditions after a 7-day bulk culture, similar immunophenotype and proliferative history were found when the standard MSC immunophenotype panel was employed, the loss of proliferative capacity in Xuri medium shows that it cannot maintain functional MSC population. This is a drastic example showing that the real MSC activity can be completely unrelated to the immunophenotype considered as MSC phenotype.
authors.affiliation: Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France.|U1035 INSERM/Bordeaux University, Bordeaux, France.
authors.forename: Sandie
authors.initials: S
authors.lastname: Gerby
authors.affiliation: Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France.|U1035 INSERM/Bordeaux University, Bordeaux, France.
authors.forename: Esther
authors.initials: E
authors.lastname: Attebi
authors.affiliation: Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France.|U1035 INSERM/Bordeaux University, Bordeaux, France.
authors.forename: Marija
authors.initials: M
authors.lastname: Vlaski
authors.affiliation: Etablissement Français du Sang Aquitaine-Limousin, Bordeaux, France.|U1035 INSERM/Bordeaux University, Bordeaux, France.
authors.forename: Zoran
authors.initials: Z
authors.lastname: Ivanovic
mesh_terms: D001854:Bone Marrow Cells / Q000166:cytology / Q000378:metabolism; D018929:Cell Culture Techniques / Q000379:methods*; D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D016895:Culture Media, Serum-Free / Q000494:pharmacology*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000378:metabolism
chemical_list: D016895:Culture Media, Serum-Free